Jason Incorporated
Records under this name other than the patents Jason Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,993,574 | Pyrrole Antifungal Agents now held by F2G Ltd. In force · High confidence | In force | High confidence | |
| US 9,187,413 | Peripherally Restricted Faah Inhibitors now held by The Regents of the University of California In force · High confidence | In force | High confidence | |
| US 10,832,286 | System and Method for Locational Messaging now held by Intercept LLC In force · High confidence | In force | High confidence | |
| US 11,669,865 | System and Method for Locational Messaging now held by Intercept LLC In force · High confidence | In force | High confidence | |
| US 9,457,101 | Hydrogels for Delivery of Therapeutic Polypeptides In force · High confidence | In force | High confidence | |
| US 9,586,950 | 2-Pyridyloxy-3-Ester-4-Nitrile Orexin Receptor Antagonists now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 9,546,152 | 2-Pyridyloxy-3-Substituted-4-Nitrile Orexin Receptor Antagonists now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 9,624,197 | 2-Pyridylamino-4-Nitrile-PIPERIDINYL Orexin Receptor Antagonists now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 9,556,145 | 2-Pyridyloxy-4-Ester Orexin Receptor Antagonists now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 9,745,284 | 2-Pyridyloxy-4-Ether Orexin Receptor Antagonists now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence |